drugset / Trial / NCT00690378
Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to determine whether NXL104 plus ceftazidime is effective in the treatment of complicated urinary tract infections as compared to a comparator group.
Timeline
- Start
- 2008-11
- Primary completion
- 2010-06
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ceftazidime | Small molecule | 500 mg | Intravenous |
| Comparator | Imipenem/Cilastatin | Unknown | 500 mg | — |
| Subject | avibactam | Small molecule | 125 mg | Intravenous |